|
KMID : 1100720130330030221
|
|
Annals of Laboratory Medicine
2013 Volume.33 No. 3 p.221 ~ p.224
|
|
|
A Novel Mutation (c.200T>C) in the NAGLU Gene of a Korean Patient with copolysaccharidosis IIIB
|
|
Kim Young-Eun
Park Hyung-Doo
Jang Mi-Ae
Ki Chang-Seok
Lee Soo-Youn
Kim Jong-Won
Cho Sung-Yoon
Jin Dong-Kyu
|
|
|
Abstract
|
|
|
|
Mucopolysaccharidosis (MPS) IIIB is a lysosomal storage disorder (LSD) caused by abnormalities of the enzyme α-N-acetylglucosaminidase (NAGLU) that is required for degradation of heparan sulfate. The patient in this study was a 4-yr-old boy. He presented with normal height and weight, pectus carinatum, and multiple persistent Mongolian spots on his back. He had mild dysmorphic features with prominent speech developmental delays and, to a lesser extent, motor developmental delays. The cetylpyridinium chloride precipitation test revealed excessive mucopolysacchariduria (657.2 mg glycosaminoglycan/g creatinine; reference range, <175 mg glycosaminoglycan/g creatinine). Thin layer chromatography showed urinary heparan sulfate excretion. NAGLU enzyme activity was significantly decreased in leukocytes (not detected; reference range, 0.9-1.51 nmol/hr/mg protein) as well as in plasma (0.14 nmol/hr/mg protein; reference range, 22.3-60.9 nmol/hr/ mg protein). PCR and direct sequencing analysis of the NAGLU gene showed that the patient was a compound heterozygote for 2 mutations: c.200T>C (p.L67P) and c.1444C>T (p.R482W). The c.200T>C mutation was a novel finding. This is the first report of a Korean patient with MPS IIIB who was confirmed by molecular genetic analyses and biochemical investigation.
|
|
|
KEYWORD
|
|
|
Korean, Mucopolysaccharidosis IIIB, NAGLU, Novel mutation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|